checkAd

     285  0 Kommentare Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union - Seite 3

    Contact Information:
    Avalon GloboCare Corp.
    4400 Route 9, Suite 3100
    Freehold, NJ 07728
    PR@Avalon-GloboCare.com 

    Investor Relations:
    Crescendo Communications, LLC
    Tel: (212) 671-1020 Ext. 304
    albt@crescendo-ir.com 



    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3
    Verfasst von globenewswire
    Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union - Seite 3 FREEHOLD, N.J., March 28, 2024 (GLOBE NEWSWIRE) - Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, is pleased to announce the extension …